$MYCB
My City Builders, Inc.

2021 Form 10-K Financial Statement

#000164033421002660 Filed on October 28, 2021

View on sec.gov

Income Statement

Concept 2021 2020 Q3 2020
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $43.80K $127.6K $162.4K
YoY Change -73.03% 403.35% 109.26%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $43.80K $127.6K $162.4K
YoY Change -73.04% 403.35% 109.26%
Operating Profit -$43.80K -$162.4K
YoY Change -73.04% 109.26%
Interest Expense $60.00K -$14.50K $35.39K
YoY Change 69.53% -79.46% 41.56%
% of Operating Profit
Other Income/Expense, Net -$60.00K -$197.6K
YoY Change -69.63% -29.48%
Pretax Income -$103.8K -$142.1K -$360.0K
YoY Change -71.17% 48.07% 0.62%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$103.8K -$142.1K -$360.0K
YoY Change -71.17% 48.07% -64.62%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$176.7K -$1.781K -$564.0K
COMMON SHARES
Basic Shares Outstanding 73.43M shares 79.79M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020 Q3 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $670.00 $1.030K $1.030K
YoY Change -34.95% -44.32% -44.32%
Cash & Equivalents $1.025K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $0.00
Receivables
Other Receivables
Total Short-Term Assets $670.00 $1.025K $1.030K
YoY Change -34.95% -44.59% -44.32%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $670.00 $1.025K $1.030K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $670.00 $1.025K $1.030K
YoY Change -34.95% -44.59% -44.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $74.98K $72.58K $72.58K
YoY Change 3.31% 21.82% 21.82%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $628.7K $568.7K $568.7K
YoY Change 10.55% 53.24% 53.24%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $957.5K $854.1K $854.1K
YoY Change 12.11% 38.9% 38.9%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $957.5K $854.1K $854.1K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $957.5K $854.1K $854.1K
YoY Change 12.11% 38.9% 38.9%
SHAREHOLDERS EQUITY
Retained Earnings -$12.71M
YoY Change 2.91%
Common Stock $11.74M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$956.8K -$853.0K -$853.0K
YoY Change
Total Liabilities & Shareholders Equity $670.00 $1.025K $1.030K
YoY Change -34.95% -44.59% -44.32%

Cashflow Statement

Concept 2021 2020 Q3 2020
OPERATING ACTIVITIES
Net Income -$103.8K -$142.1K -$360.0K
YoY Change -71.17% 48.07% -64.62%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$360.00 -$90.00 -$825.00
YoY Change -56.36% -64.0% -98.42%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$360.00 -90.00 -$825.00
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -$360.00 -90.00 -$825.00
YoY Change -56.36% -64.0% -98.42%
FREE CASH FLOW
Cash From Operating Activities -$360.00 -$90.00 -$825.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39308953 shares
CY2021Q3 us-gaap Cash
Cash
665 USD
CY2020Q3 us-gaap Cash
Cash
1025 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
665 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
1025 USD
CY2021Q3 us-gaap Assets
Assets
665 USD
CY2020Q3 us-gaap Assets
Assets
1025 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
74975 USD
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
72576 USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
234352 USD
CY2020Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
193316 USD
CY2021Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
628659 USD
CY2020Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
568659 USD
CY2021Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
19500 USD
CY2020Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
19500 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
957486 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
854051 USD
CY2021Q3 us-gaap Liabilities
Liabilities
957486 USD
CY2020Q3 us-gaap Liabilities
Liabilities
854051 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56808953 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79792286 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
56809 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
79792 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11683246 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11660263 USD
CY2021Q3 jrvs Common Stock To Be Issued
CommonStockToBeIssued
120000 USD
CY2020Q3 jrvs Common Stock To Be Issued
CommonStockToBeIssued
120000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12816876 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12713081 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-956821 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-853026 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
665 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1025 USD
CY2021 us-gaap Revenues
Revenues
0 USD
CY2020 us-gaap Revenues
Revenues
0 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
360 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
121935 USD
CY2021 us-gaap Professional Fees
ProfessionalFees
43435 USD
CY2020 us-gaap Professional Fees
ProfessionalFees
40494 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
43795 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
162429 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-43795 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-162429 USD
CY2021 jrvs Interest And Accretion On Convertible Notes
InterestAndAccretionOnConvertibleNotes
-60000 USD
CY2020 jrvs Interest And Accretion On Convertible Notes
InterestAndAccretionOnConvertibleNotes
-197570 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-60000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-197570 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-103795 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-359999 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-103795 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-359999 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73432514 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79792286 shares
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-613027 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
120000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-359999 USD
CY2021 jrvs Cancellation Of Common Stock Amount
CancellationOfCommonStockAmount
0 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-103795 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-956821 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-103795 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-359999 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
120000 USD
CY2021 us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
60000 USD
CY2020 us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
197570 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2399 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12994 USD
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
41036 USD
CY2020 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
28610 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-360 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-825 USD
CY2021 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-360 USD
CY2020 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-825 USD
CY2020Q3 us-gaap Cash
Cash
1025 USD
CY2019Q3 us-gaap Cash
Cash
1850 USD
CY2021Q3 us-gaap Cash
Cash
665 USD
CY2020Q3 us-gaap Cash
Cash
1025 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021 us-gaap Treasury Stock Retired Par Value Method Amount
TreasuryStockRetiredParValueMethodAmount
22983 USD
CY2020 us-gaap Treasury Stock Retired Par Value Method Amount
TreasuryStockRetiredParValueMethodAmount
0 USD
CY2021 us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 - ORGANIZATION AND BUSINESS OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">iMine Corporation (the “Company”) is a Nevada corporation incorporated on October 26, 2010 under the name Oconn Industries Corp. The Company’s name was changed on March 11, 2014 from Oconn Industries Corp. to Diamante Minerals, Inc. and to iMine Corporation on March 20, 2018. The change of name to iMine Corporation was effective through the merger of the Company’s wholly owned subsidiary, iMine Corporation, into the Company. The Company has one subsidiary, iMine Corporation, an Indiana corporation, which has been administratively dissolved.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During 2018, the Company was engaged in the development of the business of selling computer equipment which can be used for the mining of cryptocurrency. As a result of the decline in the price of cryptocurrency, which made the purchase of its equipment uneconomical, the Company has discontinued that business, which is reflected as a discontinued operation, and the value of the prepaid inventory, which was the only asset of the discontinued operation was fully reserved against. The Company is not engaged in any business activities and is looking to engage in another business, either through an acquisition of an existing business or by engaging a management team to develop a new business. The Company does not have any agreement to acquire any company or to bring on a management team to commence new business activities. The Company cannot give assurance that it will be successful in attracting either an acquisition candidate or a new management team. Any business the Company may acquire may be an operating business or a business with no history of earnings that is seeking to develop its business. Because of the Company’s financial condition and the market for and market price of its common stock, the Company does not believe that it would be an attractive candidate for a profitable business that is looking to go public through a reverse acquisition.</p>
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the SEC include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p>
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain reclassifications have been made to the prior year financial statements to conform to the current year presentation. The reclassifications had no impact on previously reported net loss nor accumulated deficit.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p>
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12816876 USD
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and related party payables it will likely incur in the near future. The Company places its cash with financial institutions of high credit worthiness. At times, its cash balance with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p>
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28000000 shares
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-103795 USD
CY2020 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
28610 USD
CY2020Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
193316 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
120000 USD
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
500000 USD
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
500000 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 USD
CY2020Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
500000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
500000 USD
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
128659 USD
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
68659 USD
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
628659 USD
CY2020Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
568659 USD
CY2021 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.05 pure
CY2021 us-gaap Interest Expense
InterestExpense
60000 USD
CY2020 us-gaap Interest Expense
InterestExpense
35391 USD
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
162179 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
22983333 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56808953 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79792286 shares
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-103795 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-21797 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-75600 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
21797 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
75600 USD
CY2021 jrvs Statutory Tax Benefit
StatutoryTaxBenefit
-0.21 pure
CY2020 jrvs Statutory Tax Benefit
StatutoryTaxBenefit
-0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.21 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.21 pure
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
685960 USD
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
664163 USD
CY2021Q3 jrvs Valuation Allowance
ValuationAllowance
-685960 USD
CY2020Q3 jrvs Valuation Allowance
ValuationAllowance
-664163 USD
CY2021Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q3 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
17500000 shares

Files In Submission

Name View Source Status
0001640334-21-002660-index-headers.html Edgar Link pending
0001640334-21-002660-index.html Edgar Link pending
0001640334-21-002660.txt Edgar Link pending
0001640334-21-002660-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
jrvs-20210731.xsd Edgar Link pending
jrvs-20210731_cal.xml Edgar Link unprocessable
jrvs-20210731_def.xml Edgar Link unprocessable
jrvs-20210731_lab.xml Edgar Link unprocessable
jrvs-20210731_pre.xml Edgar Link unprocessable
jrvs_10k.htm Edgar Link pending
jrvs_10kimg1.jpg Edgar Link pending
jrvs_10k_htm.xml Edgar Link completed
jrvs_ex311.htm Edgar Link pending
jrvs_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending